Test. Better. Enhanced NIPT Reporting for Patients with Positive Results

Test. Better. With the marked increase in the use of cell-free DNA screening (cfDNA/NIPT) in clinical practice, many non-invasive prenatal test (NIPT) innovations were introduced as screening technology rapidly expanded over the past decade. But which NIPT innovations are likely to tangibly improve outcomes for your practice and patients? Which NIPT innovations improve test performance and bolster confidence knowing a screening result is reliable?

This webinar will present a new bioinformatics metric which will support counseling for patients with positive results. Using real-world case studies expert speakers will discuss enhancements to test reporting and how these improvements impact the positive predictive value associated with the result. This comprehensive, evidenced-based webinar will help you: Test. Better.

Speakers

Thomas Westover, MD, FACOG, Chief of Maternal Fetal Medicine and Perinatal Genetics, Capital Health Trenton, NJ

Thomas Westover MD FACOG is currently Chair of the New Jersey Section of the American College of Obstetrics & Gynecology, President of the NJ OBGYN Society, Co-Chair of the New Jersey Hospital Association Statewide Perinatal Safety Collaborative, Chief of Maternal Fetal Medicine at Capital Health System in Trenton, NJ and Associate Professor of MFM and OBGYN at Cooper Medical School Rowan University in Camden, NJ. He serves as a member of several NJ Dept of Health Committees and assists the NJ legislature on matters related to women’s health and family health.

Message Presenter

Jill Rafalko, MS, CGC, LGC, Medical Science Liaison, Integrated Genetics

Jill Rafalko is a board certified and licensed genetic counselor.  Before joining Integrated Genetics, she worked as a prenatal genetic counselor for 8 years at New Jersey Perinatal Associates at Saint Barnabas Medical Center in Livingston, NJ. She completed her genetic counseling training at Mount Sinai School of Medicine.

Message Presenter